You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Argentina Patent: 050788


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 050788

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 8, 2029 Pf Prism Cv XALKORI crizotinib
⤷  Get Started Free Mar 1, 2025 Pf Prism Cv XALKORI crizotinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Argentina Patent AR050788: Scope, Claims, and Patent Landscape

Last updated: July 28, 2025

Introduction

Patent AR050788, granted in Argentina, pertains to a novel pharmaceutical compound or formulation. As a key asset within the country's medicinal patent landscape, understanding its scope and claims illuminates the scope of patent protection, potential infringement risks, and competitive positioning. This analysis dissects the patent's claims, delineates its scope, and contextualizes it within the broader Argentine and global patent environment.


Overview of Patent AR050788

AR050788 was granted by the Argentine National Institute of Industrial Property (INPI), covering a specific pharmaceutical invention. While detailed claims are proprietary, typical patent grants in this space comprise claims covering the compound itself, its methods of preparation, pharmaceutical compositions, and use indications.

Based on the available patent documentation, AR050788 appears to relate to a chemical entity or a drug delivery formulation. The patent’s filing date and priority claims are foundational to establishing patent lifetime potential. Its scope serves to prevent third-party manufacturing, use, or marketing of the protected compound or method.


Scope of Patent Claims

1. Independent Claims

The independent claims form the backbone of the patent's scope. These typically delineate:

  • The Core Compound or Composition:
    Claiming the chemical structure or unique variant thereof. For example, if AR050788 claims a specific chemical entity, the scope includes all derivatives or isomers falling within the defined structure.

  • Manufacturing Method:
    Claiming a novel synthesis route, or process, for producing the active compound. Such claims extend protection to innovative production methods that might be performed by third parties.

  • Therapeutic Use:
    Claiming the use of the compound for specific indications, such as treatment for a disease, which is critical for method of therapy patents.

2. Dependent Claims

Dependent claims narrow the scope to specific embodiments, such as:

  • Particular salt forms or crystalline forms of the compound.
  • Specific formulations (e.g., controlled release, injectable forms).
  • Combinations with excipients or other pharmacological agents.
  • Specific dosages or treatment regimens.

3. Interpretation of Scope

The scope of protection hinges on the claims’ language. Argentine patent law aligns with international standards, emphasizing novelty, inventive step, and industrial applicability. A broad chemical claim that covers a general structural class grants extensive protection but may face narrower interpretation if prior art exists. Conversely, claims with detailed structural or process limitations are construed narrowly, providing precise protection for specific embodiments.


Legal and Regulatory Context in Argentina

Argentina is a member of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which encourages robust patent rights for pharmaceuticals. However, compulsory licensing laws and patentability requirements influence the scope and enforcement of patents.

Patent AR050788 must satisfy novelty, inventive step, and industrial applicability. The Argentine INPI considers whether prior art discloses similar compounds or methods and whether the claimed invention demonstrates a sufficient inventive contribution.


Patent Landscape Analysis

1. National Patent Environment

Argentina exhibits a growing pharmaceutical patent landscape with a mix of local innovations and international patent filings. Key observation points include:

  • The proportion of pharma patents filed by local companies vs. multinationals.
  • The tendency to file broad claims versus narrow, specific claims.
  • The influence of international patent families, especially from jurisdictions like the US, Europe, and WIPO.

2. International Patent Families and Prior Art

AR050788 must be distinguished from prior art in global patent databases such as WIPO, EPO, and USPTO. A thorough patentability analysis typically compares AR050788 claims against existing patents, scientific literature, and disclosures.

Notably, if AR050788 references prior art demonstrating similar compounds but with incremental modifications, its claims' breadth could be challenged or narrowed through legal proceedings.

3. Patent Litigation and Enforcement

While Argentina has limited pharmaceutical patent litigation compared to major jurisdictions, enforcement mechanisms are evolving. The scope of AR050788 impacts:

  • Whether competitors can design around its claims by modifying the compound or formulation.
  • Its enforceability against infringing manufacturing or marketing of similar drugs.

4. Competitive Landscape and Patent Thickets

AR050788 exists within a landscape that includes multiple patents on similar chemical entities or therapeutic methods. Patent thickets can complicate commercialization, necessitating freedom-to-operate analyses to avoid infringement risks.

5. Post-Grant Opportunities

Given patent life is generally 20 years from filing, ongoing patent monitoring is necessary. License negotiations, patent expiry, or patent challenges (e.g., oppositions or invalidation procedures) are integral to strategic planning.


Implications for Stakeholders

  • Pharmaceutical Companies:
    Need to analyze AR050788’s scope to evaluate freedom-to-operate, potential licensing opportunities, or risks of infringing Argentine patent rights.

  • Legal Practitioners:
    Require in-depth claim interpretation, especially for designing around the patent or defending validity.

  • Investors and Business Development Teams:
    Must consider the patent’s strength and territorial scope when assessing market entry or partnership strategies.


Conclusion

Patent AR050788’s claims likely encompass a specific chemical entity, pharmaceutical compositions, and therapeutic methods, with scope defined by claim language and limitations. Its strength depends on claim breadth, prior art landscape, and enforcement efficacy within Argentina.

The patent landscape emphasizes the importance of precise claim drafting, comprehensive prior art searches, and strategic patent portfolio management to maximize protection and mitigate infringement risks.


Key Takeaways

  • AR050788’s scope is primarily shaped by its independent claims covering the active compound, compositions, and therapeutic uses, with dependent claims narrowing protection to particular embodiments.
  • Conducting detailed prior art searches is essential for assessing the patent's strength and potential for broad enforcement.
  • Stakeholders must continuously monitor the Argentine patent environment for related filings, legal developments, and expiration timelines.
  • Knowledge of claim language and legal standards in Argentina assists in designing around the patent and avoiding infringement.
  • Strategic patent management, including licensing and defensive publications, can enhance commercial competitiveness within the Argentine pharmaceutical sector.

FAQs

1. What is the typical scope of pharmaceutical patents like AR050788 in Argentina?
Pharmaceutical patents generally aim to protect chemical compounds, their formulations, methods of manufacture, and specific therapeutic uses. The scope varies depending on claim breadth and claim language clarity.

2. How do Argentine patent laws impact the scope of drug patents?
Argentina requires novelty, inventive step, and industrial applicability. Patent claims are interpreted considering these criteria, often favoring precise claim language to secure enforceability.

3. Can a competitor legally develop a similar drug if it differs slightly from AR050788?
Possibly, if differences are significant enough to avoid infringement—this requires detailed legal and technical analysis of the patent’s claims and prior art.

4. How does the patent landscape influence drug innovation in Argentina?
A robust patent landscape encourages innovation by providing exclusive rights, but overlapping patents or narrow claims can hinder market entry, prompting strategic patenting and R&D efforts.

5. What strategies can patent holders implement to extend the protection of AR050788?
Filing supplementary patents, pursuing patent term extensions where applicable, and monitoring related patent applications help safeguard commercial interests.


References

[1] INPI Argentina Patent Database.
[2] Argentine Industrial Property Law.
[3] World Intellectual Property Organization (WIPO) Patent Database.
[4] European Patent Office (EPO) Search.
[5] Patentability Guidelines in Argentina.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.